Your browser doesn't support javascript.
loading
Sex-specific differences in metabolic outcomes after sleeve gastrectomy and intermittent fasting in obese middle-aged mice.
Emiliano, Ana B; Lopatinsky, Natalie R; Kraljevic, Marko; Higuchi, Sei; He, Ying; Haeusler, Rebecca A; Schwartz, Gary J.
Affiliation
  • Emiliano AB; Columbia University Medical Center, New York, New York.
  • Lopatinsky NR; Columbia University Medical Center, New York, New York.
  • Kraljevic M; Columbia University Medical Center, New York, New York.
  • Higuchi S; Clarunis University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital, Basel, Switzerland.
  • He Y; Columbia University Medical Center, New York, New York.
  • Haeusler RA; Columbia University Medical Center, New York, New York.
  • Schwartz GJ; Columbia University Medical Center, New York, New York.
Am J Physiol Endocrinol Metab ; 323(1): E107-E121, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35658544
ABSTRACT
Despite the high prevalence of obesity among middle-aged subjects, it is unclear if sex differences in middle age affect the metabolic outcomes of obesity therapies. Accordingly, in this study, middle-aged obese female and male mice were randomized to one of three groups sleeve gastrectomy (SG), sham surgery ad libitum (SH-AL), or sham surgery with weight matching to SG through intermittent fasting with calorie restriction (SH-IF). Comprehensive measures of energy and glucose homeostasis, including energy intake, body weight, energy expenditure, glucose and insulin tolerance, and interscapular brown adipose tissue (iBAT) sympathetic innervation density were obtained. At the end of 8 wk, SG and SH-IF females had better metabolic outcomes than their male counterparts. SG females had improved weight loss maintenance, preservation of fat-free mass (FFM), higher total energy expenditure (TEE), normal locomotor activity, and reduced plasma insulin and white adipose tissue (WAT) inflammatory markers. SH-IF females also had lower plasma insulin and WAT inflammatory markers, and higher TEE than SH-IF males, despite their lower FFM. In addition, SH-IF females had higher iBAT sympathetic nerve density than SG and SH-AL females, whereas there were no differences among males. Notably, SH-IF mice of both sexes had the most improved glucose tolerance, highlighting the benefits of fasting, irrespective of weight loss. Results from this study demonstrate that in middle-aged obese mice, female sex is associated with better metabolic outcomes after SG or IF with calorie restriction. Clinical studies are needed to determine if sex differences should guide the choice of obesity therapies.NEW & NOTEWORTHY SG or IF with calorie restriction produces better metabolic outcomes in females than in males. IF with calorie restriction prevents metabolic adaptation, even in the face of fat-free mass loss. IF with calorie restriction in females only, is associated with increased iBAT sympathetic innervation, which possibly mitigates reductions in energy expenditure secondary to fat-free mass loss. Lastly, IF leads to better glucose homeostasis than SG, irrespective of sex.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Fasting / Insulins Type of study: Clinical_trials / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Am J Physiol Endocrinol Metab Journal subject: ENDOCRINOLOGIA / FISIOLOGIA / METABOLISMO Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Fasting / Insulins Type of study: Clinical_trials / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Am J Physiol Endocrinol Metab Journal subject: ENDOCRINOLOGIA / FISIOLOGIA / METABOLISMO Year: 2022 Type: Article